$APLT 90 DAYS STOCK PRICE FORECAST

Stock Price

About the Company

Applied Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of novel drug candidates against validated molecular targets in indications of high unmet medical need. The Company's lead drug candidate, AT-007, is a novel central nervous system penetrant aldose reductase inhibitor (ARI) for the treatment of Galactosemia, a rare pediatric metabolic disease. The Company initiated a pivotal Phase 1/2 clinical trial in June 2019, read out positive top-line biomarker data in adult Galactosemia patients in January 2020 and announced full data from the trial in April 2020. A pediatric Galactosemia study commenced in June 2020. The Company is also developing AT-001, a novel potent ARI that is being developed for the treatment of Diabetic Cardiomyopathy, or DbCM, a fatal fibrosis of the heart. The Company initiated a Phase 3 registrational study in DbCM in September 2019. The preclinical pipeline also includes AT-003, an ARI designed to cross through the back of the eye when dosed orally, for the treatment of diabetic retinopathy, as well as novel dual PI3k inhibitors in preclinical development for orphan oncology indications.

Exchange

NASDAQ

Website

www.appliedtherapeutics.com

$14M

Total Revenue

24

Employees

$430M

Market Capitalization

-3.77

Price/Earning ratio

Similar Companies

Name Ticker Market Capitalization (USD M) Revenue (USD M) Price/Book Price/Earning Net Margin (%)
Charles River Laboratories Int CRL 21115 3273 9.00 53.28 12.10
Exact Sciences Corp. EXAS 15524 1712 4.63 -17.52 -49.89
PRA Health Sciences Inc PRAH 10739 3333 6.88 50.52 6.40
Syneos Health Inc SYNH 9147 4730 2.78 38.89 4.99
Medpace Holdings Inc MEDP 7055 1028 7.81 40.02 17.02
Exelixis Inc EXEL 6902 1157 3.31 74.14 8.13
Twist Bioscience Corp TWST 5634 127 9.68 -42.81 -106.59
Allakos Inc ALLK 5438 9.89 -27.30 None
Vir Biotechnology Inc VIR 5162 183 7.14 -17.02 -162.74
Sana Biotechnology Inc SANA 3669 4.21 -11.20 None
Recursion Pharmaceuticals Inc RXRX 3242 9 5.07 -26.44 None
Lyell Immunopharma Inc LYEL 3126 8 3.06 -16.15 None
Instil Bio Inc TIL 2312 0 3.63 -28.00 None
Alx Oncology Holdings Inc ALXO 2166 1 5.39 -18.67 -401.23
Verve Therapeutics Inc VERV 2083 5.13 -21.06 None
Allogene Therapeutics Inc ALLO 2062 38 2.19 -8.60 -621.84
Erasca Inc ERAS 2055 -14.41 -16.25 None
Sorrento Therapeutics Inc SRNE 1840 51 11.05 -5.81 -626.43
Cortexyme Inc CRTX 1710 11.90 -19.39 None
Constellation Pharmaceuticals CNST 1564 4.32 -11.18 None
Castle Biosciences Inc CSTL 1554 78 4.09 -66.91 -28.88
Pandion Therapeutics Inc PAND 1501 1069 1.83 -13.34 -10.55
AlloVir Inc ALVR 1480 0 5.06 -12.56 -718.59
Replimune Group Inc REPL 1458 2.91 -16.17 None
Organogenesis Holdings Inc ORGO 1372 433 7.83 18.15 16.17
Rubius Therapeutics Inc RUBY 1330 5.45 -7.67 None
Y-Mabs Therapeutics Inc YMAB 1138 37 4.92 -24.73 -114.04
National Research Corp NRC 1129 140 14.47 31.01 25.62
Caribou Biosciences Inc CRBU 1098 5 -24.96 -21.71 -955.31
Century Therapeutics Inc IPSC 1076 2.42 -15.44 None
Monte Rosa Therapeutics Inc GLUE 1016 2.94 -17.64 None
Cullinan Oncology Inc CGEM 946 19 2.06 -17.35 -284.59
Scholar Rock Holding Corp SRRK 901 16 4.21 -8.33 -687.82
Precigen Inc PGEN 898 101 6.34 -8.13 -107.45
Janux Therapeutics Inc JANX 882 1 2.33 -76.82 -436.67
RAPT Therapeutics Inc RAPT 803 5 4.35 -13.37 7.14
Sutro Biopharma Inc STRO 792 69 2.83 -8.69 -114.69
Imago BioSciences Inc IMGO 776 -9.97 -29.79 None
Design Therapeutics Inc DSGN 765 0 1.91 -39.74 -245.44
MeiraGTx Holdings plc MGTX 723 19 3.80 -12.51 -325.95
Graphite Bio Inc GRPH 718 1.96 -14.58 None
Ideaya Biosciences Inc IDYA 709 36 3.65 -27.21 -84.49
Crinetics Pharmaceuticals Inc CRNX 693 0 3.99 -7.81 -447.78
Talaris Therapeutics Inc TALS 646 2.43 -18.98 None
Precision Biosciences Inc DTIL 556 101 5.88 -11.16 -45.88
Vor Biopharma Inc VOR 546 2.19 -8.34 None
Acumen Pharmaceuticals Inc ABOS 541 1 -5.30 -5.57 -550.91
Rallybio Corp RLYB 526 38 -7.86 -12.39 -1.07
Mirum Pharmaceuticals Inc MIRM 463 11 5.26 -3.04 None
Werewolf Therapeutics Inc HOWL 457 2.47 -2.45 None
Kezar Life Sciences Inc KZR 449 3.26 -9.36 None
Applied Therapeutics Inc APLT 430 14 3.84 -3.77 -19.41
Evelo Biosciences Inc EVLO 408 7.18 -3.86 None
Cue Biopharma Inc CUE 367 5 5.30 -8.50 -802.84
Oyster Point Pharma Inc OYST 360 2.38 -4.51 None
Vera Therapeutics Inc VERA 355 3.91 -6.48 None
Biomea Fusion Inc BMEA 340 1.68 -18.06 None
Sera Prognostics Inc SERA 335 0 -2.33 -14.21 None
Surface Oncology Inc SURF 329 90 2.35 14.71 18.99
Aerovate Therapeutics Inc AVTE 328 -16.22 -22.30 None
Magenta Therapeutics Inc MGTA 325 1.88 -4.68 None
Cabaletta Bio Inc CABA 312 3.20 -8.02 None
Luna Innovations Inc LUNA 299 101 3.70 129.57 2.46
Black Diamond Therapeutics Inc BDTX 284 1.14 -2.71 None
INmune Bio Inc INMB 256 0 7.54 -13.13 None
Pieris Pharmaceuticals Inc PIRS 253 24 6.35 -5.23 -203.73
Compass Therapeutics Inc CMPX 253 8.68 -3.11 None
Candel Therapeutics Inc CADL 247 0 -6.58 -7.10 None
Nextcure Inc NXTC 241 22 0.90 -3.56 -163.57
AquaBounty Technologies Inc AQB 228 0 1.30 -11.19 None
Sensei Biotherapeutics Inc SNSE 218 1.32 -7.63 None
Gemini Therapeutics Inc GMTX 211 1088 0.23 1.74 11.24
Alzamend Neuro Inc ALZN 197 12.61 -32.43 None
Impel NeuroPharma Inc. IMPL 182 3.65 -3.76 None
Elevation Oncology Inc ELEV 179 1.16 -8.02 None
Tscan Therapeutics Inc TCRX 174 6 -2.90 -5.07 -563.14
Hookipa Pharma Inc HOOK 152 20 1.20 -2.48 -304.07
Reneo Pharmaceuticals Inc RPHM 151 0.92 -5.54 None
Unity Biotechnology Inc UBX 124 1 1.93 -1.53 None
IN8bio Inc INAB 112 -5.24 -11.17 None
HCW Biologics Inc HCWB 109 4 -4.95 -16.95 -162.03
Exicure Inc XCUR 104 4 2.81 -2.19 -148.49
Axcella Health Inc AXLA 103 2700 2.21 -1.84 -10.84
Cyclerion Therapeutics Inc CYCN 90 4 1.76 -1.34 None
BioVie Inc BIVI 72 29.90 -0.40 None
Scopus Biopharma Inc SCPS 70 234 -35.55 -3.34 80.93
Eloxx Pharmaceuticals Inc ELOX 70 0 3.17 -1.28 -14.14
Synaptogenix Inc SNPX 65 2.05 -4.31 None
Monopar Therapeutics Inc MNPR 60 2.68 -7.56 None
NanoViricides Inc NNVC 54 1.88 -6.05 None
CohBar Inc CWBR 53 4.84 -3.17 None
Rezolute Inc RZLT 53 3.91 -2.43 None
Acurx Pharmaceuticals Inc ACXP 48 3.14 -6.00 None
Vaccinex Inc VCNX 47 1 3.53 -1.66 -48.71
Cyclo Therapeutics Inc CYTH 39 1 3.77 -1.86 -989.80
TransCode Therapeutics Inc RNAZ 38 -8.08 -10.86 None
Unicycive Therapeutics Inc UNCY 36 113 -8.79 -9.81 7.94
Aridis Pharmaceuticals Inc ARDS 35 0 -3.85 -1.42 -851.00
AgeX Therapeutics Inc AGE 35 2 -4.18 -3.68 -522.77
Cytocom Inc CBLI 30 0 3.88 -12.72 -912.16
Tenax Therapeutics Inc TENX 18 0 27.83 -0.71 -840.64
Geovax Labs Inc GOVX 16 1 1.30 -11.11 -558.09
Kiromic BioPharma Inc KRBP 15 6.91 -1.10 None
Xenetic Biosciences Inc XBIO 14 1 1.73 -1.07 -47.40
Neurotrope Inc NTRP 5 29 0.08 0.76 23.48

Applied Therapeutics Inc. (APLT) Upgraded to Buy: Here's Why

13d ago, source: Nasdaq

I nvestors might want to bet on Applied Therapeutics Inc. (APLT), as it has been recently upgraded to a Zacks Rank #2 (Buy). This upgrade primarily reflects an upward trend in earnings estimates, ...

Applied Therapeutics Reports Additional Pediatric Biomarker Data from ACTION-Galactosemia Kids

1d ago, source: Middle East North Africa Financial Network

Substantial and statistically significant reduction in plasma galactitol of 40% with new weight-based dosing parameters Baseline galactitol l ...

Applied Therapeutics Inc (APLT)

20d ago, source: Investing.com

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all ...

Applied Therapeutics Inc 2UV

22d ago, source: Morningstar%2c Inc.

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.

Foghorn Therapeutics Announces Presentation at Upcoming 4th Annual Targeted Protein Degradation ...

14h ago, source: Associated Press

Foghorn Therapeutics Inc. (Nasdaq: FHTX), a company pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory ...

NeuroSense Therapeutics Publicly Files Registration Statement with SEC for Proposed U.S. Initial Public Offering

18h ago, source: Business Insider

NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company focused on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases, announced ...

Context Therapeutics Slashes Expected IPO Price

1d ago, source: MarketWatch

By Colin Kellaher Context Therapeutics Inc. on Monday slashed the expected price of its initial public offering to $5 a share from an earlier estimate of ...

BRIEF-Xilio Therapeutics Inc Files For IPO Of Up To $100 Million

18d ago, source: MSN

XILIO THERAPEUTICS INC FILES FOR IPO OF UP TO $100 MILLION - SEC FILING * XILIO THERAPEUTICS INC SAYS APPLIED TO LIST COMMON STOCK ON NASDAQ UNDER SYMBOL “XLO” * XILIO THERAPEUTICS INC SAYS ...

Relief Reports Half-Year 2021 Results and Provides Corporate Update

26d ago, source: PharmiWeb

In March 2021, Relief signed a Collaboration and License Agreement with Acer Therapeutics, Inc. (Acer) for the worldwide development ... be launched in both the U.S. and Europe during 2022. APR ...

Applied Therapeutics Inc APLT

20d ago, source: Morningstar%2c Inc.

There is no one analyst in which a Quantitative Star Rating and Fair Value Estimate is attributed to; however, Mr. Lee Davidson, Head of Quantitative Research for Morningstar, Inc., is responsible ...

Foghorn Therapeutics Announces Presentation at Upcoming 4th Annual Targeted Protein Degradation Summit

14h ago, source: YAHOO!Finance

David Millan, PhD, VP of Chemistry, to present overview of company’s proprietary protein degrader platform and its clinical stage asset, FHD-609, a potent and selective heterobifunctional degrader of ...

Your Portfolio